Recent Updates
Recently added Catalysts
PEN Positive Sentiment

Penumbra, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 1, 2023 Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2023 after market...

Key Takeaway: Penumbra, Inc. has announced a conference call scheduled for August 1, 2023, to discuss its financial results for the second quarter of 2023. The call will take place after market close at 4:30 PM Eastern Time. A press release detailing the financial performance will be issued prior to the call, and the event will be accessible via phone or webcast from the company's website.
Price reaction · baseline $338.77 (2023-07-03 close) · hit after-hours · clean, no other PEN news in the window
day 0 close · peak
-0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Scheduled earnings conference indicates transparency with investors.
  • Company continues to focus on innovative therapies.
  • Expected press release may provide insights into financial performance.

Full Press Release Details

ALAMEDA, Calif. , July 5, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that it will host a conference call to discuss financial results for the second quarter 2023 after market close on Tuesday, August 1, 2023 at 4:30 PM Eastern Time . A press release with second quarter 2023 financial results will be issued after market close that day.
Webcast & Conference Call Information The conference call can be accessed live over the phone by dialing (888) 330-2443 for domestic and international callers (conference id: 4604622), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at: www.penumbrainc.com . The webcast will be available on the Company's website for at least two weeks following the completion of the call.
About Penumbra Penumbra, Inc., headquartered in Alameda, California , is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn .

Frequently Asked Questions

When will Penumbra announce its Q2 2023 financial results?

Penumbra will announce its Q2 2023 financial results on August 1, 2023.

How can I access the conference call for Penumbra's Q2 results?

You can dial (888) 330-2443 or access the webcast on Penumbra's website.

Where can I find the Penumbra Q2 webcast after the call?

The webcast will be available on the company's website for at least two weeks.

What does Penumbra focus on in the healthcare industry?

Penumbra focuses on innovative therapies for challenging medical conditions.

In how many countries does Penumbra operate?

Penumbra supports healthcare providers in over 100 countries worldwide.

Last updated: Jul 5, 2023